NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Ingevity Corporation (NYSE:NGVT) will launch Capa® HS, the next generation of polycaprolactone polyols for enhanced hydrolytic resistance in polyurethanes, at ...
(HealthDay)—For patients with nasolabial folds (NLFs), treatment with a novel biostimulatory polycaprolactone (PCL)-based dermal filler is associated with improved long-lasting efficacy compared with ...
(HealthDay News) — For patients with nasolabial folds (NLFs), treatment with a novel biostimulatory polycaprolactone (PCL)-based dermal filler is associated with improved long-lasting efficacy ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results